y.ramos
TL2 Moderator · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 23 December 2024 · last posted 2d
85 posts, newest first. Showing up to 150.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #76 · Sourcing › Regulatory · 26 Jul 2026 · 29 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #52 · Pharmacology › Receptor biology · 22 Jul 2026 · 3 likes Coming back to post #50, because the follow-up matters more than the original answer. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin…
-
Request: a per-category review queue Replied, post #112 · Meta › Feature requests · 18 Jul 2026 · 0 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #76 · Start Here › Welcome · 11 Jul 2026 · 19 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Seven-day rolling means and why weekly readings mislead Replied, post #12 · Outcomes › Progress reports · 11 Jul 2026 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #86 · Compounds › Repair & healing peptides · 7 Jul 2026 · 0 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
What to include when your question involves a chromatogram — one year on Replied, post #64 · Start Here › How to Ask · 5 Jul 2026 · 5 likes Coming back to post #62, because the follow-up matters more than the original answer. Avoid "any advice?" at the end. It is so generic that people do not know which…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #76 · Wellbeing › Sleep · 4 Jul 2026 · 19 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
About the Welcome category Replied, post #8 · Start Here › Welcome · 30 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Semaglutide and alcohol: what is actually documented Replied, post #12 · Compounds › Semaglutide · 26 Jun 2026 · 0 likes Picking up post #9: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #120 · Clinical › Bloodwork · 23 Jun 2026 · 0 likes Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #69 · Practice › Interactions · 22 Jun 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #22 · Evidence › Journal club · 8 Jun 2026 · 30 likes I read post #20 twice before replying, because I had assumed the opposite. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point…
-
Blinding yourself: practical methods and their limits Replied, post #31 · Research Methods › N-of-1 designs · 4 Jun 2026 · 2 likes I read post #29 twice before replying, because I had assumed the opposite. Confounding in personal experiments: other things change when you start a medication (season,…
-
A critique that turned out to be unfair, retracted by its author Replied, post #7 · Evidence › Study critique · 4 Jun 2026 · 0 likes This follows post #4 rather than contradicting it. What makes a methodological criticism substantive: it identifies a specific feature of the design that materially…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #65 · Compounds › Repair & healing peptides · 3 Jun 2026 · 10 likes post #64 is right about the mechanism and I think understates the practical bit. The absence of adequately powered published randomised human trials is the central fact…
-
Why the timeline is on the right and not the left — what changed since Replied, post #43 · Meta › Site feedback · 26 May 2026 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #46 · Sourcing › Red flags · 14 May 2026 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #2 · Access › Shortages · 12 May 2026 · 7 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Does a peptide degrade silently, with no visual change? Replied, post #24 · Practice › Storage & stability · 10 May 2026 · 8 likes This follows post #21 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #62 · Sourcing › Logistics · 6 May 2026 · 8 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #88 · Practice › Reconstitution · 23 Apr 2026 · 0 likes post #87 answers the question as asked. The question underneath it is different. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #63 · Practice › Reconstitution · 22 Apr 2026 · 11 likes Coming back to post #61, because the follow-up matters more than the original answer. A vial that will not fully dissolve: check in order: is the diluent genuinely room…
-
The headache that turns out to be dehydration — the long version Replied, post #20 · Nutrition & Training › Hydration & electrolytes · 11 Apr 2026 · 18 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #73 · Compounds › Tirzepatide · 7 Apr 2026 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Follow-up: State-level differences that actually matter Started this topic · Regional › North America · 3 Apr 2026 · 25 likes State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail…
-
Why this subcategory is stricter about sourcing than most Replied, post #11 · Compounds › Secretagogues & GH axis · 24 Mar 2026 · 1 like Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
-
Revisiting: Maintainer handover: how it works Replied, post #49 · Meta › Wiki maintenance · 13 Mar 2026 · 5 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Amylin receptor signalling and satiety — what changed since Replied, post #42 · Pharmacology › Receptor biology · 10 Mar 2026 · 4 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #64 · Pharmacology › Pharmacokinetics · 8 Mar 2026 · 8 likes On post #60 — agreed on the reasoning, with one qualification. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #7 · Lounge › Introductions · 7 Mar 2026 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
MHRA statements, read directly Replied, post #102 · Regional › UK & Ireland · 5 Mar 2026 · 2 likes Worth separating two things that post #98 runs together. Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and…
-
Contributing data without breaching anyone's privacy Replied, post #37 · Data & Tools › Datasets · 4 Mar 2026 · 9 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Solubility limits and what a cloudy solution is telling you Replied, post #4 · Pharmacology › Formulation chemistry · 26 Feb 2026 · 2 likes post #2 answers the question as asked. The question underneath it is different. Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #77 · Meta › Site feedback · 20 Feb 2026 · 17 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #94 · Compounds › Oral incretins · 1 Feb 2026 · 4 likes On post #90 — agreed on the reasoning, with one qualification. Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of…
-
Managing an unplanned gap in supply Replied, post #6 · Access › Shortages · 14 Jan 2026 · 14 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
A partial dose because the pen emptied mid-injection Replied, post #46 · Practice › Administration · 8 Jan 2026 · 1 like This follows post #43 rather than contradicting it. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up)…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #18 · Data & Tools › Calculators · 8 Jan 2026 · 0 likes This follows post #15 rather than contradicting it. Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can…
-
MHRA statements, read directly Replied, post #57 · Regional › UK & Ireland · 28 Dec 2025 · 2 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
Aggregates and why a purity assay may miss them entirely Replied, post #28 · Analytics › Impurities & related substances · 25 Dec 2025 · 0 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #114 · Start Here › How to Ask · 19 Nov 2025 · 0 likes post #113 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
[2026 update] What steady state means for the decision to escalate Replied, post #120 · Practice › Dosing & titration · 17 Nov 2025 · 8 likes post #119 answers the question as asked. The question underneath it is different. Dose equivalence between different incretin analogues is a weak concept. The molecules…
-
Pen dose counters: what a click does and does not guarantee Replied, post #63 · Devices › Pens & autoinjectors · 16 Nov 2025 · 11 likes Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Documentation that appears only after payment Replied, post #78 · Sourcing › Red flags · 16 Nov 2025 · 0 likes Worth separating two things that post #74 runs together. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get…
-
Realistic expectations for strength while losing weight quickly Replied, post #33 · Nutrition & Training › Resistance training · 3 Nov 2025 · 26 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #84 · Practice › Reconstitution · 23 Oct 2025 · 1 like Worth separating two things that post #80 runs together. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
New subcategory: rationale and scope Replied, post #59 · Meta › Announcements · 19 Oct 2025 · 25 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Titles that describe the question, not the situation Replied, post #110 · Start Here › How to Ask · 1 Oct 2025 · 5 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #108 · Practice › Side effects · 1 Oct 2025 · 6 likes On post #104 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #66 · Compounds › Semaglutide · 28 Sep 2025 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #16 · Compounds › Semaglutide · 16 Sep 2025 · 33 likes I read post #14 twice before replying, because I had assumed the opposite. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology…
-
"Should I double up?" — answered once, at length, calmly Replied, post #14 · Practice › Administration · 26 Aug 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Official shortage notices and what they authorise Replied, post #91 · Access › Shortages · 15 Aug 2025 · 16 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
A request that was declined, and the reasoning — a second dataset Replied, post #52 · Documentation › Wiki requests · 11 Aug 2025 · 0 likes Worth separating two things that post #48 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #25 · Access › Insurance & coverage · 8 Jun 2025 · 19 likes This follows post #22 rather than contradicting it. Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper…
-
Follow-up: What other technical communities get right that we do not Replied, post #119 · Lounge › Off topic · 3 Jun 2025 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #83 · Practice › Reconstitution · 2 Jun 2025 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #79 · Wellbeing › Mental health · 24 Apr 2025 · 17 likes Coming back to post #77, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Reading order for a first week here, and what to skip until later Replied, post #50 · Start Here › Welcome · 24 Mar 2025 · 29 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #109 · Compounds › Semaglutide · 20 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Payment mechanics and the recovery options that do not exist — what changed since Started this topic · Sourcing › Payments · 15 Mar 2025 · 0 likes On the subject in the title: Payment mechanics and the recovery options that do not exist — what changed since Working notes rather than a conclusion. A logistics…
-
Reading a chromatogram someone posted without axes Replied, post #10 · Analytics › HPLC & UHPLC · 11 Mar 2025 · 26 likes This follows post #7 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Albumin binding and how it produces a long half-life Replied, post #13 · Pharmacology › Pharmacokinetics · 11 Mar 2025 · 6 likes Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #83 · Sourcing › Regulatory · 3 Mar 2025 · 8 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #68 · Sourcing › Regulatory · 2 Mar 2025 · 3 likes post #67 is right about the mechanism and I think understates the practical bit. Approval versus licensing: a compound can be approved for a specific indication in one…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #13 · Sourcing › Independent verification · 20 Feb 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Assessing a warm arrival: the decision process Replied, post #4 · Sourcing › Logistics · 18 Feb 2025 · 2 likes Coming back to post #3, because the follow-up matters more than the original answer. Reshipment after seizure: if a parcel is seized, some suppliers will reship; others…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #52 · Analytics › Mass spectrometry · 9 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #7 · Documentation › Doc review · 31 Jan 2025 · 29 likes Coming back to post #5, because the follow-up matters more than the original answer. Evidence synthesis requests: if you think a page should summarise the state of…
-
Reading a supplementary appendix and finding the interesting part Replied, post #72 · Evidence › Trials · 20 Jan 2025 · 0 likes On post #68 — agreed on the reasoning, with one qualification. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the…
-
Recovery when intake is low: what to cut first Replied, post #91 · Nutrition & Training › Resistance training · 15 Jan 2025 · 0 likes post #90 is right about the mechanism and I think understates the practical bit. Post-weight-loss training: once weight loss is complete and energy deficit ends,…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #18 · Evidence › Meta-analyses · 13 Jan 2025 · 22 likes Coming back to post #16, because the follow-up matters more than the original answer. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #112 · Analytics › Method validation · 6 Jan 2025 · 26 likes Picking up post #109: that is the part I would want checked first. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
-
What we do not know about retatrutide, listed explicitly Replied, post #44 · Compounds › Retatrutide · 5 Jan 2025 · 0 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #118 · Compounds › Oral incretins · 28 Dec 2024 · 3 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #78 · Practice › Side effects · 16 Dec 2024 · 4 likes On post #74 — agreed on the reasoning, with one qualification. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #67 · Compounds › Tirzepatide · 3 Dec 2024 · 27 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
When "no data" is the complete and final answer Replied, post #30 · Compounds › Other compounds · 28 Nov 2024 · 18 likes Worth separating two things that post #26 runs together. Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #35 · Compounds › Other compounds · 6 Oct 2024 · 6 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #2 · Wellbeing › Mental health · 17 Sep 2024 · 27 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
Coming back to: Oxidation pathways for methionine and tryptophan Started this topic · Analytics › Impurities & related substances · 7 Aug 2024 · 0 likes Oxidation pathways for methionine and tryptophan Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #5 · Practice › Side effects · 26 Jul 2024 · 18 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #25 · Practice › Dosing & titration · 19 Jun 2024 · 6 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Spreadsheets: an appreciation Replied, post #15 · Lounge › Off topic · 7 Jun 2024 · 22 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.